Owner

Dayesha Rathuwaduge

Verification

Tags

⭐ 20% That Gives 80% — Defense of Tonicity

1. What exactly is being defended? → ECF Tonicity

• Tonicity = effective osmolality of ECF, determined mainly by:
• Na⁺ (major)
• K⁺ (minor contribution)
• Total body osmolality ∝ (Total Na⁺ + Total K⁺) ÷ Total Body Water.
• Cells depend on a constant “internal sea” → ECF around them.

👉 Exam Pearl:

When Na⁺/K⁺ and water mismatch → TONICITY changes → vasopressin & thirst fix it.

2. Main Defenders → Vasopressin + Thirst

Vasopressin (ADH)

• Released from posterior pituitary.
• Controlled mainly by plasma osmolality.
• Hypertonic blood (↑ osmolality) → ADH ↑:
• Kidneys retain water
• Urine becomes concentrated
• Plasma becomes diluted

→ Brings osmolality back to normal.

Thirst

• Hypertonicity also triggers thirst center.
• Person drinks → water intake increases → plasma becomes less concentrated.

👉 Together, ADH and thirst return tonicity to normal.

3. What if plasma becomes too dilute (hypotonic)?

• ADH secretion falls → kidneys excrete solute‐free water.
• This prevents over-dilution of ECF.

4. Normal Plasma Osmolality Values (EXTREMELY EXAM-RELEVANT)

Normal: 280–295 mOsm/kg

• ADH maximally suppressed: ~285 mOsm/kg
• ADH stimulated: above this level

👉 These numbers appear in SBAs and MCQs repeatedly.

⭐ One-line summary you must remember for exams

“ECF tonicity is defended by ADH and thirst: hypertonic → ADH ↑ + thirst ↑; hypotonic → ADH ↓ and solute-free water excretion.”

⭐ 20% That Gives 80% — Vasopressin (ADH) Receptors & Actions

1. Three Vasopressin Receptors — KNOW THIS TABLE (SUPER HIGH-YIELD)

👉 If you remember this table, you can answer 90% of MCQs on vasopressin.

⭐ 2. Main Physiological Effect — Water Retention (via V2)

• Vasopressin = ADH = antidiuretic hormone, because:
• It makes collecting ducts permeable to water.
• Inserts Aquaporin-2 channels into the apical membrane of principal cells.
• Water moves into the hypertonic medulla → concentrated urine.

👉 Result:

Retains water > solute → ↓ plasma osmolality (dilutes the ECF).

⭐ 3. What happens when vasopressin is ABSENT?

• Aquaporin-2 not inserted → ducts are water-impermeable.
• Urine becomes:
• Dilute (hypotonic)
• Large volume
• Net effect: water loss → plasma osmolality rises.

👉 Classic physiology: ADH absence = water diuresis.

⭐ 4. V1A Effects — Vasoconstriction + BP Support

• V1A receptors cause:
• Vasoconstriction
• Glycogenolysis (liver)
• Actions in brain
• BUT: In vivo large doses needed for major BP rise because:
• Vasopressin also reduces cardiac output via brain action (area postrema).

👉 High-yield clinical physiology:

Hemorrhage strongly stimulates ADH → helps maintain BP.

⭐ 5. V1B (V3) — Link to the Stress Axis

• Located in anterior pituitary.
• Stimulates ACTH release from corticotropes.

👉 High-yield pearl:

CRH + ADH together → ACTH release.

⭐ 6. Metabolism

• Half-life ≈ 18 minutes (short!).
• Destroyed mainly in liver + kidneys.

👉 Explains why ADH levels adjust quickly to osmotic changes.

⭐ ULTRA-CONDENSED EXAM SUMMARY

V2: kidney → cAMP → AQP2 → water retention.

V1A: vessels → Ca²⁺ → vasoconstriction + BP support (especially in hemorrhage).

V1B: pituitary → Ca²⁺ → ↑ ACTH.

🧠 EXAM REFLEX BLOCK — Defense of Tonicity & Vasopressin (ADH)

(Read this before SBAs / MCQs — rapid trigger–response memory)

🔹 CORE DEFENDED VARIABLE

• ECF tonicity = effective plasma osmolality
• Determined mainly by Na⁺, minor K⁺
• Formula logic:

(Total Na⁺ + Total K⁺) ÷ Total body water

👉 Reflex:

Na⁺–water mismatch → tonicity disturbed → ADH + thirst respond

🔹 PRIMARY DEFENDERS

• Vasopressin (ADH) → minute-to-minute control
• Thirst → behavioral backup

👉 Reflex pair:

Hypertonic = ADH ↑ + thirst ↑

Hypotonic = ADH ↓ + water excretion ↑

🔹 PLASMA OSMOLALITY NUMBERS (NON-NEGOTIABLE)

• Normal: 280–295 mOsm/kg
• ADH suppressed: ~285
• ADH stimulated: >285

👉 Exam trap:

Volume status ≠ tonicity control

→ ADH responds primarily to osmolality, not volume (unless severe hemorrhage)

🔹 VASOPRESSIN RECEPTORS — INSTANT TABLE RECALL

👉 One reflex line:

V2 = water, V1A = vessels, V1B = ACTH

🔹 ABSENCE OF ADH — THINK DI

• No AQP-2 insertion
• Collecting duct water-impermeable
• Large volume, dilute urine
• Plasma osmolality rises

👉 Phrase examiners love:

“ADH absence causes solute-free water diuresis.”

🔹 HEMORRHAGE LOGIC (COMMON SBA TWIST)

• Severe blood loss → non-osmotic ADH release
• V1A-mediated vasoconstriction helps BP
• Even if plasma is hypotonic → ADH may still rise

👉 Reflex:

Osmolality dominates normally, volume dominates in shock

🔹 STRESS AXIS LINK

• CRH + ADH → ACTH release
• Explains ↑ cortisol during stress

👉 MCQ hook:

If ACTH ↑ despite normal CRH → ADH involvement

🔹 PHARMACOKINETIC PEARL

• Half-life ≈ 18 minutes
• Cleared by liver + kidneys

👉 Allows rapid fine-tuning of tonicity

🧨 FINAL ONE-LINE EXAM LOCK

“ECF tonicity is defended by ADH and thirst: hypertonic → ADH ↑ + thirst ↑; hypotonic → ADH ↓ with solute-free water excretion.”

⭐Control of Vasopressin (ADH) Secretion

1. MAIN CONTROL = OSMOLALITY (THE MOST IMPORTANT FACT IN THE ENTIRE TOPIC)

• ADH secretion begins when plasma osmolality > ~285 mOsm/kg.
• Below 285 → ADH almost zero (maximally suppressed).
• Above 285 → ADH secretion increases steeply.

👉 This is the central feedback system that keeps plasma osmolality ≈ 285 mOsm/kg.

⭐ 2. WHERE IS THE SENSOR? — Anterior Hypothalamus Osmoreceptors

• Located in circumventricular organs, especially:
• OVLT (Organum Vasculosum of Lamina Terminalis)
• These areas are outside the blood–brain barrier → can detect plasma osmolality directly.

👉 OVLT = primary osmoreceptor for ADH.

⭐ 3. THIRST vs. ADH — Same Threshold (or Thirst is Slightly Higher)

• Thirst and ADH rise at almost the same osmolality.
• Thirst threshold is equal or slightly greater than ADH threshold.

👉 This ensures ADH acts first, then thirst kicks in if hypertonicity continues.

⭐ 4. Sensitivity — ADH Detects ~1% Change

• VERY small changes (≈1% change in osmolality) → significant change in ADH release.
• This is why plasma osmolality is so tightly regulated.

👉 ADH system is the most sensitive volume/osmolality regulator in the body.

⭐ 5. NON-OSMOTIC STIMULI — VERY IMPORTANT FOR CLINICAL PHYSIOLOGY

ADH INCREASES with (memorize this list):

• ↑ Plasma osmolality (MOST IMPORTANT)
• ↓ ECF volume / hemorrhage
• Pain
• Emotional stress
• Exercise
• Nausea & vomiting (STRONGEST NON-OSMOTIC STIMULUS)
• Standing
• Drugs: clofibrate, carbamazepine
• Angiotensin II

👉 If volume loss is severe → ADH secretion occurs even if plasma is hypotonic.

ADH DECREASES with:

• ↓ Plasma osmolality
• ↑ ECF volume
• Alcohol (important cause of dilute urine → dehydration after drinking)

⭐ 6. ULTRA-CONDENSED EXAM SUMMARY

ADH is mainly controlled by hypothalamic osmoreceptors in OVLT; secretion starts above 285 mOsm/kg; thirst threshold slightly higher; ADH is extremely sensitive (1% changes); volume loss, nausea, pain, stress ↑ ADH; alcohol ↓ ADH.

🧠 EXAM REFLEX BLOCK — Control of Vasopressin (ADH) Secretion

MASTER FACT (lock this first)

• Primary controller of ADH = plasma osmolality
• Threshold ≈ 285 mOsm/kg
• < 285 → ADH almost zero
• > 285 → ADH rises steeply
• Purpose: keep plasma osmolality tightly around 285 mOsm/kg

WHERE IS THE SENSOR?

• Anterior hypothalamic osmoreceptors
• Located in circumventricular organs
• OVLT (Organum Vasculosum of Lamina Terminalis) = main sensor
• Outside BBB → senses plasma directly

Reflex:

OVLT = osmolality sensor for ADH + thirst

ADH vs THIRST — ORDER OF DEFENCE

• ADH threshold ≈ thirst threshold
• Thirst is same or slightly higher
• Meaning:
• ADH acts first
• Thirst is backup if hypertonicity persists

SENSITIVITY (VERY EXAM-LOVED)

• ~1% change in osmolality → large ADH change
• Makes ADH the most sensitive regulator of internal environment

NON-OSMOTIC CONTROL (CLINICAL GOLD)

ADH INCREASES with

• ↑ Plasma osmolality (most important)
• ↓ ECF volume / hemorrhage
• Nausea & vomiting ⭐ strongest non-osmotic
• Pain
• Emotional stress
• Exercise
• Standing
• Angiotensin II
• Drugs: carbamazepine, clofibrate

👉 Severe volume loss overrides osmolality

→ ADH released even if plasma is hypotonic

ADH DECREASES with

• ↓ Plasma osmolality
• ↑ ECF volume
• Alcohol → ↓ ADH → dilute urine → dehydration

ONE-LINE EXAM LOCK

ADH secretion is primarily controlled by OVLT osmoreceptors, begins above 285 mOsm/kg, is exquisitely sensitive (≈1%), precedes thirst, is powerfully increased by nausea and volume loss, and is inhibited by alcohol.

⚠️ COMMON MCQ TRAPS

• ADH is not primarily volume-controlled
• Nausea > pain > stress (non-osmotic strength)
• Alcohol causes water diuresis, not osmotic diuresis
• Volume loss can override hypotonic suppression

⭐ Volume Effects on Vasopressin (ADH)

1. Volume Control Is SECOND System (after Osmolality)

• Low ECF volume = ↑ ADH
• High ECF volume = ↓ ADH

👉 Even if osmolality is LOW, severe hypovolemia will STILL raise ADH.

This is one of the most important clinical points.

⭐ 2. Who Senses Volume? — Stretch Receptors

Two types of “volume sensors” send signals to hypothalamus:

Low-pressure receptors (MAIN ones for ADH volume control)

• Located in:
• Great veins
• Right & left atria
• Pulmonary vessels
• Detect vascular fullness (central venous pressure).
• Moderate blood volume loss → ↓ stretch → ↑ ADH even before BP drops.

👉 Most important for volume-dependent ADH secretion.

High-pressure receptors

• Carotid sinus
• Aortic arch
• Detect arterial pressure; respond mainly when BP falls.

👉 Severe hypotension → exponential rise in ADH.

⭐ 3. Neural Pathway (Keep this short — enough for exams)

• Stretch receptor afferents → Vagus nerve → NTS → CVLM → Hypothalamus
• Less stretch = less inhibition = more ADH.

You will get full marks if you simply remember:

Low-pressure atrial receptors → vagus → NTS → hypothalamus.

⭐ 4. Angiotensin II Further Boosts ADH

• Ang II acts on circumventricular organs.
• Reinforces ADH secretion during hypovolemia / hypotension.

👉 ATII + ADH work together in volume depletion.

⭐ 5. Hypovolemia Shifts ADH Curve LEFT

In hypovolemia:

• ADH is released at lower osmolality.
• Curve becomes steeper → stronger ADH response.

👉 This causes water retention → ↓ osmolality → hyponatremia.

Very common clinical exam scenario.

⭐ 6. Other Stimuli That Increase ADH

• Pain
• Nausea (STRONGEST non-osmotic stimulus)
• Surgical stress
• Emotional stress

👉 Nausea = massive ADH release.

⭐ 7. What Decreases ADH?

• Alcohol
• Increased ECF volume
• Low plasma osmolality

⭐ ULTRA-CONDENSED EXAM SUMMARY

Low-volume states → ↓ stretch at atrial receptors → vagus → NTS → ↑ ADH. Hypovolemia shifts ADH curve left → ADH released even at low osmolality → water retention → hyponatremia. Nausea = biggest ADH trigger; alcohol = strong inhibitor.

🧠 Volume Effects on Vasopressin (ADH) — EXAM-PERFECT NOTE

🔹 Core Principle

• ADH is primarily regulated by plasma osmolality
• ECF volume is the SECOND controller — but it OVERRIDES osmolality when volume loss is significant

👉 Key rule:

Severe hypovolemia → ↑ ADH even if plasma osmolality is low

🔹 Who Senses Volume? — Stretch Receptors

⭐ Low-pressure receptors (MOST IMPORTANT)

• Location:
• Great veins
• Right & left atria
• Pulmonary vessels
• Sense vascular fullness / central venous pressure
• ↓ Stretch (moderate volume loss) → ↑ ADH

(Occurs before BP falls)

👉 Main volume sensors for ADH are low pressure receptors

⭐ High-pressure receptors

• Carotid sinus
• Aortic arch
• Respond mainly to marked hypotension

👉 Important only in severe BP drop

🔹 Neural Pathway (Exam-sufficient)

• ↓ Stretch at atrial receptors→ Vagus nerve→ Nucleus tractus solitarius (NTS)→ Hypothalamus→ ↑ ADH

📌 Memory line:

Atria → vagus → NTS → hypothalamus→ ↑ ADH

🔹 Role of Angiotensin II

• Acts on circumventricular organs
• Directly stimulates ADH
• Synergizes with ADH during hypovolemia / hypotension

👉 RAAS + ADH work together

🔹 Effect on ADH–Osmolality Curve

• Hypovolemia shifts curve LEFT
• ADH released at lower plasma osmolality
• Curve becomes steeper

👉 Leads to water retention → dilutional hyponatremia

⚠️ Very common exam scenario

🔹 Non-osmotic Stimuli Increasing ADH

• Nausea ⭐⭐⭐ (strongest)
• Pain
• Surgical stress
• Emotional stress

👉 Nausea = massive ADH release

🔹 Factors That Decrease ADH

• Alcohol 🍺
• Increased ECF volume
• Low plasma osmolality

🚨 ULTRA-CONDENSED EXAM REFLEX

Low ECF volume → ↓ atrial stretch → vagus → NTS → ↑ ADH → left-shifted ADH curve → water retention → hyponatremia.

Strongest trigger = nausea | Strong inhibitor = alcohol

⭐ Clinical Physiology of Vasopressin

1. Why ADH Becomes “Inappropriate” in Clinical Settings

Non-osmotic triggers (pain, stress, nausea, hypovolemia) override the normal osmotic control.

👉 After surgery or trauma:

• Pain + stress + mild hypovolemia → ↑ ADH
• Water retention → dilutional hyponatremia (low Na⁺)
• Even if plasma osmolality is already low

This is a classic exam scenario.

⭐ 2. DIABETES INSIPIDUS — Two Types, One Logic

Problem: Inability to retain water → polyuria + polydipsia

Urine = large volume, very dilute.

A. Central DI = ADH deficiency

Damage to:

• Supraoptic nucleus
• Paraventricular nucleus
• Hypothalamo–hypophyseal tract
• Posterior pituitary

Common causes (remember 30–30–30 rule):

• 30% tumors (primary + metastatic)
• 30% trauma
• 30% idiopathic
• Remaining: infections, vascular lesions, sarcoidosis, genetic mutations

💡 Postoperative DI may be temporary if axons recover → ADH secretion resumes.

B. Nephrogenic DI = kidney unresponsive to ADH

Two causes you MUST remember:

1. V2 receptor mutation

• X-linked recessive
• Receptor doesn’t respond to ADH

2. Aquaporin-2 mutation

• Autosomal
• AQP2 channels are defective or trapped in cells → cannot reach apical membrane

👉 Both cause dilute urine even though ADH levels are normal or high.

⭐ 3. Key Clinical Feature: Polyuria + Polydipsia

If thirst mechanism fails → severe dehydration (can be dangerous).

Thirst is what keeps DI patients stable.

⭐ 4. SIADH — ADH Too High for the Serum Osmolality

Definition:

ADH secretion is inappropriately high relative to low serum osmolality.

Consequences:

• Water retention → dilutional hyponatremia
• Extra water expansion suppresses aldosterone → salt loss in urine

👉 This explains low Na⁺ AND high urine Na⁺ → exam classic.

Common causes

• CNS disease → “cerebral salt wasting”
• Pulmonary disease (pneumonia, TB)
• Small cell lung cancer → tumor secretes ADH
• Loss of vagal inhibitory afferents (from stretch receptors) → uninhibited ADH release

⭐ 5. "Vasopressin Escape" — Very High-Yield Concept

Body protects itself from massive hyponatremia.

Mechanism:

• Prolonged high ADH → kidney down-regulates Aquaporin-2 channels
• Water reabsorption suddenly decreases
• Urine flow increases → limits the hyponatremia

👉 This is why chronic SIADH does not cause endless water retention.

⭐ 6. Treatment Highlight for SIADH

Demeclocycline

• Antibiotic
• Blocks renal response to ADH
• Useful when water restriction fails

(Modern alternatives include vaptans, but demeclocycline is classic exam knowledge.)

⭐ ULTRA-CONDENSED EXAM SUMMARY

• Non-osmotic stimuli (pain, nausea, hypovolemia) → ↑ ADH → dilutional hyponatremia.
• DI = Low ADH (central) OR kidney unresponsive (nephrogenic) → polyuria, dilute urine, polydipsia.
• Central DI causes: 30% tumors, 30% trauma, 30% idiopathic.
• Nephrogenic DI causes: V2 mutation (X-linked) or AQP2 mutation.
• SIADH = ADH too high → hyponatremia + salt loss in urine; lung tumors common.
• Vasopressin escape = down-regulation of AQP2 → limits hyponatremia.
• Demeclocycline reduces renal ADH response.

🔒 VASOPRESSIN (ADH) — EXAM REFLEX BLOCK

1️⃣ When ADH becomes “inappropriate”

• Non-osmotic stimuli override osmolality→ Pain, stress, nausea, hypovolemia
• Post-op / trauma patient

→ ↑ ADH despite low osmolality

→ Water retention → dilutional hyponatremia

👉 Classic post-surgical hyponatremia scenario.

2️⃣ Diabetes Insipidus = water loss problem

Core picture:

• Polyuria + polydipsia
• Dilute urine
• Survival depends on intact thirst

A. Central DI (↓ ADH)

• Damage to:
• Supraoptic / paraventricular nuclei
• Hypothalamo-hypophyseal tract
• Posterior pituitary
• 30–30–30 rule:
• 30% tumors
• 30% trauma
• 30% idiopathic
• Post-op DI may be transient (axon recovery)

B. Nephrogenic DI (ADH resistance)

• ADH normal or high
• Two must-know causes:
• V2 receptor mutation (X-linked)
• Aquaporin-2 mutation (autosomal)
• Result: AQP2 fails to insert → no water reabsorption

3️⃣ SIADH = too much ADH for the osmolality

• Water retention → dilutional hyponatremia
• ECF expansion → ↓ aldosterone → ↑ urinary sodium loss

👉 Low serum Na⁺ + high urine Na⁺ = SIADH

Common causes

• CNS disease
• Pulmonary disease (pneumonia, TB)
• Small-cell lung carcinoma
• Loss of vagal inhibitory input from stretch receptors

4️⃣ Vasopressin escape (very high-yield)

• Chronic ADH excess→ Down-regulation of AQP2
• ↓ water reabsorption despite ADH
• Protects against severe hyponatremia

👉 Explains why SIADH doesn’t cause infinite water retention.

5️⃣ Treatment pearl

• Demeclocycline
• Induces nephrogenic DI
• Used when fluid restriction fails
• (Vaptans = modern, but demeclocycline = exam favorite)

⚡ ONE-LINE MEMORY LOCK

ADH disorders = mismatch between water and sodium control:

↓ ADH or resistance → DI (polyuria);

↑ ADH without need → SIADH (hyponatremia);

chronic excess → AQP2 escape.

⭐ Synthetic ADH Agonists & Antagonists

1. Desmopressin (dDAVP) — THE MOST IMPORTANT POINT

• 1-deamino-8-D-arginine vasopressin
• Modified synthetic ADH analogue
• Extremely high V2 (antidiuretic) activity
• Very low V1 (pressor) activity

👉 This makes desmopressin the preferred treatment for:

• Central diabetes insipidus
• Nocturnal enuresis
• Mild hemophilia A (because it ↑ factor VIII & vWF)
• von Willebrand disease

→ Key exam point: Desmopressin = “pure V2 agonist.”

Why is this important?

Natural vasopressin has:

• V1 effects → vasoconstriction (pressor)
• V2 effects → renal water retention

Desmopressin is engineered so:

• V2 >> V1
• Thus: strong antidiuretic effect with minimal effect on BP

2. Vasopressin Antagonists (just the essentials)

• V2 receptor blockers = Vaptans

(e.g., Tolvaptan, Conivaptan)

👉 Used in SIADH to block excessive ADH effect and correct hyponatremia.

Just knowing vaptans = ADH antagonists is enough for exams.

⭐ ULTRA-CONDENSED EXAM SUMMARY

Desmopressin = synthetic ADH analogue, V2-selective → strong antidiuretic effect, minimal vasoconstriction. Used in central DI and some bleeding disorders. Vaptans = ADH antagonists used in SIADH.

✅ ECF Volume Control

1. ECF Volume = Total Body Sodium (MOST IMPORTANT POINT)

• ECF volume is determined by Na⁺ amount, not water.
• Na⁺ is the main osmole in ECF → therefore controls ECF volume.

👉 Exam line:

“ECF volume = total Na⁺ content; osmolality = water balance.”

2. Sodium Balance Is Controlled Mainly by the Kidney

Two ways the kidney regulates Na⁺:

a. GFR changes

• Low ECF volume → low BP → low GFR → less Na⁺ filtered → Na⁺ retention.

b. Tubular reabsorption changes

• Low ECF → ↑ aldosterone → ↑ Na⁺ reabsorption.

3. Key Hormones Controlling ECF Volume

(1) RAAS – Responds to LOW volume

Low volume → ↑ renin → ↑ angiotensin II → ↑ aldosterone → Na⁺ retention.

Angiotensin II also:

• Stimulates thirst
• Stimulates vasopressin (ADH)
• Causes vasoconstriction

All help maintain BP.

👉 Angiotensin II = master hormone for hypovolemia.

(2) Vasopressin (ADH)

• Normally controlled by osmolality
• BUT volume changes override osmolality.

Low volume → ADH ↑

→ water retention → helps restore volume.

(3) ANP & BNP – Respond to HIGH volume

• From atria (ANP) and ventricles (BNP)
• Triggered by ECF expansion

Effects:

• Natriuresis (Na⁺ loss)
• Diuresis (water loss)
• Dilate afferent arteriole
• ↓ renin, ↓ aldosterone, ↓ ADH

👉 ANP/BNP = defense against hypervolemia.

4. What Happens in Disease?

a. Water loss (dehydration)

• Water leaves both ICF + ECF
• ECF volume ↓ moderately

b. Sodium loss (diarrhea, adrenal insufficiency)

• ECF volume ↓ severely
• Can → shock

👉 Na⁺ loss is far more dangerous than water loss.

c. Adrenal insufficiency

• Cannot retain sodium
• Na⁺ even shifts into cells → worsening ECF depletion.

5. Fast vs Slow Regulation of Na⁺ Excretion

Slow (hours to days): Aldosterone

Works via gene transcription → slow.

Fast (minutes): Hemodynamic changes

Example: Standing up

• Immediate ↓ Na⁺ excretion
• Seen even after adrenalectomy → NOT due to aldosterone
• Likely due to:
• ↓ ANP
• renal sympathetic activity
• renal vasoconstriction

6. Extra Points to Grab Marks

• Kidney also produces renin, EPO, 1,25(OH)₂D₃.
• Natriuretic hormones include:
• ANP/BNP (heart)
• endogenous ouabain → inhibits Na⁺/K⁺ ATPase → natriuresis.

⭐ SUPER-SHORT HIGH-YIELD SUMMARY

• ECF volume = total Na⁺.
• Low volume → RAAS + ADH ON.
• High volume → ANP/BNP ON.
• Low GFR = Na⁺ retention.
• Aldosterone = slow; hemodynamic reflexes = fast.
• Na⁺ loss = dangerous → shock.

✅ RENIN — The 20% Core That Gives 80% Marks

1. What Renin Is (one-liner you must memorise)

Renin = an aspartyl protease enzyme made by the kidney that cleaves angiotensinogen → angiotensin I.

👉 This single line answers 70% of exam questions.

2. Where It Comes From

• Produced ONLY by kidneys

✔ Secreted by juxtaglomerular (JG) cells in the afferent arteriole.

✔ Active renin disappears after nephrectomy → PROVES kidneys are the exclusive source.

• Prorenin:
• Larger inactive precursor.
• Secreted by kidneys and some extra-renal tissues (ovaries, placenta).
• But only kidneys convert prorenin → renin (in secretory granules).

⭐ Exam-cracker line:

Circulating prorenin can rise after nephrectomy, but active renin falls to zero.

3. Why It’s Special

Renin is an aspartyl protease → it has aspartic acid residues at its active site (Asp-104 & Asp-292).

👉 This detail often appears in physiology MCQs.

4. Structure (simplified for exams)

• Precursor: Preprorenin = 406 aa
• Becomes prorenin = 383 aa
• Active renin = 340 aa

⭐ Only renin is biologically active.

⭐ Prorenin is biologically inactive.

5. What Renin Does — The One Job

Renin cleaves angiotensinogen (from liver) → Angiotensin I (10 aa).

ACE then converts it → Angiotensin II, the powerful vasoconstrictor.

⭐⭐ If you remember ONLY this function, you score most marks.

6. Why & When Renin Is Released (clinically key)

Renin release ↑ when kidneys sense:

✔ Low blood pressure (afferent arteriole stretch ↓)

✔ Low NaCl delivery to macula densa

✔ High sympathetic activity (β1 receptors)

👉 These three triggers = “B.P. ↓, Salt ↓, Sympathetic ↑”.

This is the clinically useful physiology that explains:

• Renal artery stenosis → ↑ renin
• Heart failure → ↑ renin
• β-blockers → ↓ renin
• NSAIDs → ↓ renin via afferent constriction

7. Half-life & Secretion Pattern

• Active renin half-life ≈ 80 minutes
• Prorenin = constitutive secretion
• Renin = regulated secretion from JG granules

This helps you answer MCQs on kinetics.

⭐ ULTRA-HIGH-YIELD SUMMARY TABLE

⭐ ONE-LINE EXAM PEARL (memorise)

“Renin from JG cells is an aspartyl protease that converts angiotensinogen → Ang I; regulated by BP, macula densa, and sympathetic tone.”

✅ ANGIOTENSINOGEN — 20% That Scores 80%

1. What It Is

Angiotensinogen = liver-made α₂-globulin that renin acts on to start RAAS.

👉 Renin cuts angiotensinogen → Angiotensin I (10 aa).

That is the MAIN exam point.

2. Who Produces It

• Synthesized by the liver
• Released into circulation
• 453 amino acids long (large glycoprotein, ~13% carbohydrate)

⭐ Made as a precursor with a 32-aa signal peptide removed in ER

(Only needed for protein synthesis MCQs.)

3. What Increases Angiotensinogen Levels

Very high-yield list:

• Estrogen (→ explains pregnancy ↑ RAAS & ↑ angiotensinogen)
• Glucocorticoids
• Thyroid hormones
• Cytokines
• Angiotensin II itself (positive feedback)

👉 This is why oral contraceptives can raise BP.

⭐ ONE-LINE EXAM PEARL

“Angiotensinogen is a liver α₂-globulin upregulated by estrogen, thyroid hormone, glucocorticoids & angiotensin II.”

✅ ACE & ANGIOTENSIN II — The 20% Core

1. ACE’s Key Function

ACE converts Angiotensin I → Angiotensin II by removing His-Leu (a dipeptide).

👉 ACE = dipeptidyl carboxypeptidase.

2. ACE’s Second Major Function

ACE inactivates bradykinin (a vasodilator).

⭐ High-yield clinical link:

ACE inhibitors → ↑ bradykinin → dry cough (20% of patients).

3. Where ACE Is Located

• Mainly in endothelial cells
• Highest density in lungs → MAIN site of Ang II formation
• Also present in systemic vasculature and tissues

👉 Blood flowing through pulmonary endothelium = main zone of Ang II production.

⭐ Mini-Pearl

“ACE lives on endothelial surfaces—especially lungs.”

4. ACE Forms (High-yield structural differences)

ACE exists as two isoforms from the same gene:

Somatic ACE

• 170 kDa
• Two extracellular domains → TWO active sites
• Found throughout the body

Germinal (testis) ACE

• 90 kDa
• One extracellular domain → ONE active site
• Found only in post-meiotic spermatogenic cells + sperm

⭐ Both have:

• Single transmembrane domain
• Short cytoplasmic tail

This explains knockout phenotypes.

5. ACE Gene Knockout Findings (Key exam points)

• Males:
• Low BP
• Reduced fertility
• Females:
• Normal BP
• Normal fertility

👉 Shows somatic ACE needed for BP regulation; germinal ACE needed for male fertility.

⭐ ONE-LINE EXAM PEARL

“ACE converts Ang I → Ang II and destroys bradykinin; somatic ACE has two active sites, testis ACE has one.”

🧠 Put Everything Together (Memory-friendly Summary)

⭐ SUPER HIGH-YIELD FINAL LINE

“Liver makes angiotensinogen; renin makes Ang I; ACE in lung endothelium makes Ang II and destroys bradykinin.”

✅ 1. METABOLISM OF ANGIOTENSIN II — SUPER HIGH-YIELD

Half-life

• Very short: 1–2 minutes.

👉 Explains why RAAS acts fast and requires continuous production.

How Ang II is broken down

Ang II → rapidly metabolized by aminopeptidases:

1. Remove Asp (Asp¹) → forms Angiotensin III (7 aa)
• Has 40% of pressor effect
• 100% aldosterone-stimulating effect
2. Remove next N-terminal residue → Angiotensin IV (6 aa)
• Minor activity (mainly research interest)

👉 MCQ trick:

Ang III = strong aldosterone stimulator; weaker vasoconstrictor.

Where metabolism happens

• Many tissues, red blood cells
• Vascular beds trap & remove Ang II

👉 Helps maintain tight local control of BP.

Renin Measurement (High yield for clinical physiology)

• PRA (Plasma Renin Activity) = angiotensin I generated per hour
• Problem: Low angiotensinogen → falsely low PRA
• Solution: Add exogenous angiotensinogen → measure Plasma Renin Concentration (PRC)

Normal values:

• PRA ≈ 1 ng Ang I/mL/hour
• Ang II ≈ 25 pg/mL

⭐ ONE-LINE PEARL

“Ang II is short-lived, broken to Ang III (aldosterone stimulator), measured indirectly via PRA/PRC.”

✅ 2. ACTIONS OF ANGIOTENSIN II — THE 20% EXAM GOLD

A. Vascular Actions (MOST IMPORTANT)

Ang II = one of the most potent vasoconstrictors in humans.

• Increases systolic + diastolic BP
• Acts on arterioles → ↑ systemic vascular resistance

👉 4–8× stronger than norepinephrine (weight basis)

Down-regulation clue:

• In Na⁺ depletion, cirrhosis, etc. → chronic high Ang II
• Receptors down-regulate → ↓ response to injected Ang II

B. Adrenal Cortex

Strong stimulus for aldosterone release.

⭐ This is the RAAS link you must always remember.

C. Kidney Actions

• Constricts efferent arteriole → ↓ renal blood flow, maintains GFR
• Contracts mesangial cells → ↓ filtration surface → ↓ GFR
• Directly increases Na⁺ reabsorption in proximal tubule

D. Sympathetic Nervous System

• Enhances norepinephrine release
• Increases sympathetic tone

👉 Helps maintain BP in shock states.

E. Brain Effects (VERY HIGH-YIELD)

Ang II cannot cross the BBB, but acts on circumventricular organs:

1. Area postrema → decreases baroreflex sensitivity → enhances pressor response
2. SFO + OVLT → stimulates thirst (dipsogenic effect)
3. Increases vasopressin (ADH)
4. Increases ACTH

⭐ Remember: Ang II acts on brain regions OUTSIDE the BBB.

F. Angiotensin III & IV

• Ang III:
• 40% pressor effect
• 100% aldosterone stimulation
• Ang IV: minor activity

👉 Breakdown products, not major physiologic regulators.

⭐ HIGH-YIELD SUMMARY TABLE

⭐ ONE-LINE EXAM MASTER PEARL

“Ang II is short-lived, extremely potent, raises BP via arteriolar constriction, stimulates aldosterone, enhances sympathetic tone, triggers thirst/ADH via circumventricular organs, and its metabolites (Ang III/IV) are minor players.”

✅ RAAS DRUGS

There are 4 main places you can block the RAAS pathway:

1️⃣ Reduce Renin Secretion (UPSTREAM BLOCK)

Mechanism: stop the kidney from releasing renin.

Drugs:

• Prostaglandin inhibitors (e.g., indomethacin)
• β-blockers (e.g., propranolol, atenolol)

Why they work:

• Renin release depends on:
• Prostaglandins (stimulators)
• β₁-receptors on JG cells

Block these → renin secretion ↓

💎 High-yield rule:

β-blockers ↓ renin → ↓ Ang II → ↓ BP.

2️⃣ Block Renin’s Enzymatic Activity

Mechanism: prevent renin from making angiotensin I.

Drugs:

• Pepstatin (experimental peptide inhibitor)
• Direct renin inhibitors (e.g., enalkiren, aliskiren family)

💎 These directly shut down the first step of RAAS.

3️⃣ ACE Inhibitors (THE MOST IMPORTANT CLINICALLY)

Mechanism: block conversion of Ang I → Ang II.

Drugs:

• Captopril
• Enalapril
• (lisinopril, ramipril, etc.)

Key exam points:

• ↓ Ang II → ↓ vasoconstriction + ↓ aldosterone
• ↑ bradykinin → dry cough & angioedema

💎 ACE inhibitors block RAAS and increase bradykinin.

4️⃣ Block Angiotensin II Receptors (DOWNSTREAM BLOCK)

A. Competitive Ang II analogs (older drugs)

• Saralasin
• Block both AT₁ & AT₂ receptors
• Rarely used now

B. Selective AT₁ blockers (modern ARBs)

• Losartan
• Others: valsartan, candesartan

💎 AT₁ = vasoconstriction + aldosterone

→ Blocking AT₁ gives effects similar to ACE inhibitors WITHOUT cough.

C. Selective AT₂ blockers

• PD-123177
• Experimental, not used clinically

⭐ HIGH-YIELD SUMMARY TABLE (Memorise This)

⭐ ONE-LINE EXAM PEARL

“RAAS can be blocked at 4 levels: ↓ renin release → renin inhibition → ACE inhibition → Ang II receptor blockade.”

⭐ ULTRA-SHORT VERSION FOR LAST-MINUTE REVISION

• β-blockers + NSAIDs ↓ renin
• Renin inhibitors stop Ang I formation
• ACE inhibitors stop Ang II + ↑ bradykinin (→ cough)
• ARBs (losartan) block AT₁ receptors → same effect without cough

✅ 1. TISSUE RENIN–ANGIOTENSIN SYSTEMS — The 20% You Must Know

A. Local RAAS exists in many tissues

Many organs have their own local RAAS that makes Angiotensin II locally (not for circulation).

Found in:

• Blood vessel walls
• Uterus, placenta, fetal membranes
• Amniotic fluid (high prorenin)
• Eyes
• Exocrine pancreas
• Heart
• Fat
• Adrenal cortex
• Testis, ovary
• Pituitary
• Pineal
• Brain

💎 Key fact:

These tissues make Ang II locally but do NOT contribute to circulating renin.

👉 How we know:

After nephrectomy, PRA drops to zero, even though tissues still contain RAAS components.

B. Why tissue RAAS is important

Evidence shows:

Angiotensin II acts as a growth factor for:

• Heart muscle
• Vascular smooth muscle

→ Causes hypertrophy & remodeling

→ A major reason ACE inhibitors / ARBs improve heart failure outcomes.

💎 High-yield rule:

ACE inhibitors/ARBs help heart failure partly because they stop Ang II–induced cardiac/vessel hypertrophy.

⭐ ONE-LINE PEARL

“Tissues make their own Ang II for local effects—especially growth; kidney renin makes the circulating pool.”

✅ 2. ANGIOTENSIN II RECEPTORS — AT₁ & AT₂ (20% That Scores 80%)

There are two major receptor types:

A. AT₁ Receptors — THE MAIN CLINICAL RECEPTOR

1. Function

AT₁ mediates ALL classical Ang II effects:

• Vasoconstriction
• Aldosterone release
• Sympathetic stimulation
• Sodium retention
• Cardiac/vascular hypertrophy

💎 AT₁ = the dangerous BP-raising receptor.

2. Signalling

• Gq protein → PLC → ↑ IP₃ & ↑ DAG → ↑ intracellular Ca²⁺
• Activates tyrosine kinases
• Located in caveolae (invaginated membrane microdomains)

3. Subtypes

In rodents:

• AT₁A: blood vessels, brain → major physiologic effects
• AT₁B: anterior pituitary + adrenal cortex → aldosterone secretion

In humans:

• One confirmed AT₁ gene on chromosome 3

4. Regulation (VERY HIGH-YIELD)

• Chronic high Ang II → ↓ vascular AT₁ receptors (down-regulation)
• But ↑ adrenal AT₁ receptors (up-regulation → more aldosterone)

💎 Opposite regulation in vessels vs. adrenal cortex.

⭐ ONE-LINE PEARL

“AT₁ = Gq → Ca²⁺ ↑ → vasoconstriction, aldosterone, growth.”

B. AT₂ Receptors — The OPPOSITE RECEPTOR

1. Function

AT₂ receptors generally oppose AT₁ receptor effects.

They:

• Activate phosphatases
• Open K⁺ channels
• Increase NO → ↑ cGMP

Effects:

• Vasodilation
• Anti-growth / anti-remodelling

💎 AT₂ = protective, antihypertrophic, fetal-type receptor.

2. Distribution

• Abundant in fetus & neonate
• Persist in brain, some adult tissues

3. Signalling

• Uses a G-protein
• Increases NO
• Increases cGMP

⭐ ONE-LINE PEARL

“AT₂ = NO/cGMP, vasodilation & anti-growth; fetal receptor with protective roles.”

⭐ HIGH-YIELD SUMMARY TABLE

⭐ ULTRA-SHORT VERSION FOR 30-SECOND REVISION

• Tissue RAAS = local Ang II → growth/hypertrophy
• AT₁ = Gq, vasoconstriction, aldosterone, growth
• AT₂ = NO/cGMP, vasodilation, anti-growth
• High Ang II ↓ AT₁ in vessels but ↑ AT₁ in adrenal

✅ 1. What the Juxtaglomerular Apparatus (JGA) Is — SUPER HIGH-YIELD

The JGA = 3 structures working together to regulate renin & GFR:

1. JG cells (juxtaglomerular cells)

• Modified smooth muscle cells in afferent arteriole wall
• Contain renin-filled granules
• Main source of renin in the body
• Sense afferent arteriole pressure

2. Macula densa

• Specialized cells in early distal tubule
• Sense Na⁺/Cl⁻ delivery from Loop of Henle
• Communicate directly with JG cells

3. Lacis cells (extraglomerular mesangial cells)

• Between afferent & efferent arterioles
• Contain prorenin/renin
• Exact function unclear (low-yield)

💎 One-line pearl:

JGA = JG cells (renin) + macula densa (salt sensor) + lacis cells (support).

✅ 2. Regulation of Renin Release — THE MOST IMPORTANT EXAM TOPIC

Renin secretion is controlled by 3 major mechanisms:

⭐ A. Intrarenal baroreceptor (pressure sensor in afferent arteriole)

• Low pressure → ↑ renin
• High pressure → ↓ renin

👉 Kidney literally “feels” pressure.

⭐ B. Macula densa (salt sensor)

Low Na⁺/Cl⁻ delivery → ↑ renin

High Na⁺/Cl⁻ → ↓ renin

• Uses Na–K–2Cl transporter
• Likely via NO and paracrine signals

👉 Explains why loop diuretics → ↑ renin

(because they block Na-K-2Cl → kidney thinks salt is low).

⭐ C. Sympathetic nervous system (MOST POWERFUL STIMULATOR)

• β₁ receptors on JG cells → ↑ renin via ↑ cAMP
• Activated by:
• Hypotension
• Low CVP
• Standing
• Dehydration
• Shock
• Stress / psychological stimuli

👉 Explains why β-blockers ↓ renin and ↓ BP.

🟥 Inhibitors of Renin Secretion

• High Na⁺/Cl⁻ at macula densa
• High afferent arteriolar pressure
• Angiotensin II (negative feedback)
• Vasopressin

🟩 Stimulators of Renin Secretion

• Sympathetic activity (β₁)
• Circulating catecholamines
• Prostaglandins
• Low Na⁺ intake / Na⁺ depletion
• Diuretics
• Hypotension / hemorrhage
• Dehydration
• Heart failure
• Cirrhosis
• Renal artery stenosis
• Standing / upright posture
• Stress / psychological triggers

💎 One-line pearl:

Anything that lowers renal perfusion → ↑ renin.

⭐ Why K⁺ seems to change renin

K⁺ changes Na⁺/Cl⁻ delivery → indirectly affects renin.

(Not a direct K⁺ → JG cell signal.)

✅ 3. CLINICAL HIGH-YIELD: Renin and Hypertension

Renal Artery Stenosis = “Goldblatt Hypertension”

Constriction of ONE renal artery → ↓ pressure at JG cells → huge ↑ in renin → Ang II–mediated hypertension.

Two types:

1. One-clip, two-kidney

• One kidney ischemic → ↑ renin
• Other kidney normal but retains Na⁺ & water from RAAS
• HIGH renin hypertension
• Clinical correlate: unilateral renal artery stenosis

2. One-clip, one-kidney

• Only one kidney present & clipped
• Renin may be normal or low

Why?

• Mechanism unclear
• But hypertension persists due to volume retention

Treatment relevance:

ACE inhibitors or ARBs lower BP even when renin is normal or low.

⭐ ULTRA-HIGH-YIELD PEARLS (MEMORISE THESE)**

1. JG cells release renin; macula densa senses salt; lacis cells support.

2. Biggest triggers of renin = “3 LOWs”

• Low BP
• Low NaCl
• Low blood volume (via ↑ SNS)

3. β₁ activation = STRONG renin stimulus.

4. Loop diuretics ALWAYS ↑ renin.

5. Ang II inhibits renin (negative feedback).

6. Renal artery stenosis → high renin → high BP.

7. ACE inhibitors/ARBs work even when renin is low.

⭐ QUICK TABLE FOR EXAM REVISION

⭐ ONE-LINE MASTER PEARL

“Renin release = low pressure, low salt, high sympathetic tone; renal artery stenosis causes high renin hypertension.”

💥 NATRIURETIC PEPTIDES (20% → 80% MARKS)

1. What are they? — 3 MAIN PEPTIDES

• ANP (Atrial Natriuretic Peptide)
• Secreted mainly from atria
• 28 amino acids, with a 17-AA ring
• Released when ECF expands / Na⁺ intake increases / atrial stretch
• BNP (B-type Natriuretic Peptide)
• Secreted mainly from ventricles (humans)
• 32 amino acids, same 17-AA ring
• Rises more in ventricular failure → main clinical biomarker
• CNP (C-type Natriuretic Peptide)
• Found in brain, pituitary, kidney, endothelium
• Paracrine hormone, minimal in circulation

2. Core Actions — The Examiner’s Favourite

A. Kidney

Main mechanism: ↑ GFR + ↓ Na⁺ reabsorption → Natriuresis

1. Dilates afferent arteriole → ↑ RPF → ↑ GFR
2. Relaxes mesangial cells → ↑ filtration surface area
3. Inhibits Na⁺ reabsorption in tubules
4. Net effect = more Na⁺ + water lost

👉 Bottom line: “Flushes salt + water OUT.”

B. Blood Vessels

• Vasodilation (both arteries + veins)
• ↓ BP
• CNP is the strongest venous dilator

C. Hormonal Opposites

They counteract RAAS + catecholamines:

• ↓ Renin
• ↓ Aldosterone
• ↓ Angiotensin II effects
• Oppose vasopressin

👉 Think: ANP/BNP = Anti-RAAS.

3. How Does the Brain Use ANP?

• ANP neurons in hypothalamus → brainstem cardiovascular centers
• Opposes angiotensin II + vasopressin
• Promotes natriuresis + lower blood pressure

👉 Central effect = BP lowering + RAAS suppression.

4. The ONE-LINE ULTRA-HIGH-YIELD SUMMARY

“ANP/BNP come from the heart when stretched → ↑ GFR, ↑ Na⁺ loss, vasodilate, and block RAAS.”

This alone gets you 80% of SBA questions right.

5. EXAM TRIGGERS

• Heart failure → BNP rises
• Volume expansion → ANP release
• Mechanism of natriuresis → afferent dilation + mesangial relaxation
• Opposes RAAS → ↓ renin, ↓ aldosterone
• CNP → paracrine, vascular, not cardiac

💥 NATRIURETIC PEPTIDE RECEPTORS & SECRETION (20% → 80% MARKS)

1. THREE NPR RECEPTORS — THE EXAM CORE

1️⃣ NPR-A → Main ANP & BNP receptor

• Transmembrane receptor
• Cytoplasmic guanylyl cyclase → ↑ cGMP
• Highest affinity for ANP
• Mediates:
• ↑ GFR
• ↑ Natriuresis
• Vasodilation
• RAAS inhibition

👉 If ANP is acting → it is NPR-A.

2️⃣ NPR-B → Main CNP receptor

• Also has guanylyl cyclase → ↑ cGMP
• Highest affinity for CNP
• Mostly acts as paracrine vascular dilator

👉 CNP → NPR-B.

3️⃣ NPR-C → Clearance receptor

• Binds all three peptides (ANP/BNP/CNP)
• Truncated cytoplasmic tail
• Main function: removal/clearance of peptides
• Internalizes them
• Releases later → stabilizes plasma levels
• Some evidence: may signal via G-proteins (PLC activation, AC inhibition)
• But main role = clearance

👉 NPR-C = “Catcher + Clearer.”

2. SECRETION — THE STRETCH RULE (VERY HIGH YIELD)

ANP secretion ↑ when:

• Atrial stretch (↑ central venous pressure)
• ECF expansion (saline infusion)
• Neck-deep water immersion
• → increases central blood volume
• → ↓ renin & ↓ aldosterone

ANP FALLS when standing up (↓ venous return → ↓ atrial stretch).

BNP secretion ↑ when:

• Ventricular stretch
• Strongly elevated in heart failure
• Used clinically for diagnosis & monitoring of HF

👉 ANP = atrial stretch; BNP = ventricular stretch.

3. METABOLISM — SHORT HALF-LIFE

• ANP rapidly degraded by neutral endopeptidase (NEP)
• NEP inhibitor thiorphan → ↑ circulating ANP
• BNP also cleared by NEP + NPR-C

👉 NEP = main destroyer of ANP/BNP.

4. “NA,K-ATPase–INHIBITING FACTOR” — EXAM TRAP

Not a natriuretic peptide.

It is another natriuretic factor found in blood, likely:

• Ouabain (digitalis-like steroid)
• From adrenal gland
• Inhibits Na⁺/K⁺ ATPase → natriuresis
• BUT raises blood pressure (opposite of ANP/BNP)

👉 Ouabain = natriuresis WITH hypertension.

ONE-LINE ULTRA-HIGH-YIELD SUMMARY

“NPR-A = ANP/BNP → cGMP; NPR-B = CNP → cGMP; NPR-C = clearance. ANP = atrial stretch; BNP = ventricular stretch; NEP destroys them; ouabain inhibits Na⁺/K⁺ ATPase but increases BP.”

✅ ERYTHROPOIETIN (HIGH-YIELD)

1. What triggers EPO? (Absolute core)

⭐ Main stimulus = Hypoxia

• Low O₂ → ↑ EPO transcription → ↑ RBC production.
• O₂ sensor = heme protein
• Deoxy-form → stimulates EPO gene
• Oxy-form → inhibits EPO gene

Additional stimuli (remember: “C.A.A.”)

• Cobalt salts
• Alkalosis (high altitude)
• Androgens

👉 Clinical memory: High-altitude → alkalosis + hypoxia → BIG EPO surge.

2. Where does EPO come from? (Very high yield)

Adults

• Kidney — 85% → produced by interstitial cells in peritubular capillaries
• Liver — 15% → perivenous hepatocytes

👉 Clinical pearl:

If kidneys fail → liver cannot up-regulate enough → anemia in CKD.

Extra sites (important MCQs)

• Brain → neuroprotection during hypoxia
• Uterus & oviducts → estrogen-induced; role in angiogenesis
• Spleen & salivary glands contain EPO protein but do NOT make it (no mRNA).

3. What does EPO do? (Ultra-exam-yield)

Main function: Increase RBC production

• Acts on committed erythroid progenitors → prevents apoptosis
• More cells survive → more reticulocytes → more RBCs
• Uses cytokine receptor family
• Single transmembrane receptor
• Activates tyrosine kinase → downstream serine/threonine kinases

👉 Key fact: Reticulocyte rise takes 2–3 days (RBC maturation is slow).

4. How is EPO handled in the body?

• Half-life ~5 hours
• Mainly inactivated in liver
• Effect (rise in RBC count) appears after 48–72 hours

5. Clinical applications (must-remember for exams)

⭐ Recombinant EPO = Epoetin alfa

Used for:

• Anemia in chronic renal failure (90% of dialysis patients)
• Pre-operative autologous blood donation

6. Relationship with other systems

• Catecholamines stimulate EPO (β-adrenergic mechanism)
• BUT this has nothing to do with the renin–angiotensin system (separate pathways).

🚀 ULTRA-SHORT EXAM VERSION (just 8 lines)

• Stimulus: Hypoxia (heme sensor: deoxy = ↑EPO, oxy = ↓EPO).
• Sites: Kidney 85% (interstitial cells), liver 15% (perivenous).
• Functions: Prevents apoptosis of erythroid precursors → ↑RBCs.
• Receptor: Cytokine receptor → tyrosine kinase pathway.
• Kinetics: Half-life 5 hrs; RBC rise 2–3 days.
• Inactivation: Liver mainly.
• Stimulators: Hypoxia, cobalt, androgens, high-altitude alkalosis.
• Clinical: CKD anemia; recombinant epoetin alfa used therapeutically.